TGFB1 and open-angle glaucoma: This interaction between IL-6 and sIL6R is known to exhibit the inhibitory action of TGF-β-induced up-regulation of fibrotic changes in vitro49, suggesting that trans-signalling of IL-6 could be a potential target of POAG treatment.